SCN1A and Dravet syndrome: Evidence in clinical studies,8, 13 non‐mammalian DS models,16 and mammalian non‐DS models17 suggests that fenfluramine may also affect phenotypes that are caused by Scn1a haploinsufficiency but not necessarily secondary to seizures.